Pfizer expects $15B revenue from COVID-19 vaccine - News - Dukascopy Bank

Sat, 29 May 2021 14:31:21 GMT
Source: Dukascopy Bank SA
 
Pfizer plans to generate $15B in revenue from sales of its COVID-19 vaccine developed together with the German partner BioNTech.

Back to feed
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.